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Abstract
Background: Glucose restriction in cells increases the AMP/ATP ratio (energetic stress), which activates the AMPK/p53
pathway. Depending upon the energetic stress levels, cells undergo either autophagy or cell death. Given that the activated
p53 induces the expression of IFI16 protein, we investigated the potential role of the IFI16 protein in glucose restriction-
induced responses.
Methodology/Principal Findings: We found that glucose restriction or treatment of human diploid fibroblasts (HDFs) with
the activators of the AMPK/p53 pathway induced the expression of IFI16 protein. The induced levels of IFI16 protein were
associated with the induction of autophagy and reduced cell survival. Moreover, the increase in the IFI16 protein levels was
dependent upon the expression of the functional ATM protein kinase. Importantly, the knockdown of the IFI16 expression
in HDFs inhibited the activation of the ATM/AMPK/p53 pathway in response to glucose restriction and also increased the
survival of HDFs.
Conclusions/Significance: Our observations demonstrate a role for the IFI16 protein in the energetic stress-induced
regulation of autophagy and cell survival. Additionally, our findings also indicate that the loss of IFI16 expression, as found
in certain cancers, may provide a survival advantage to cancer cells in microenvironments with low glucose levels.
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Introduction
Ataxia Telangiectasia (A-T) is an inherited disorder [1,2]. The
clinical presentations of the AT are due to an autosomal recessive
mutation in the Ataxia Telangiectasia (ATM) gene. The ATM
protein is a ,370 kDa Ser/Thr kinase, which is localized in the
cytoplasm and nucleus [2]. In response to oxidative stress, ATM
protein is phosphorylated at Ser-1981 [1,2]. This phosphorylation
activates the kinase activity, which results in phosphorylation of its
substrates, including the AMP-activated protein kinase-a
(AMPKa) and p53 [2,3]. Interestingly, activation of the ATM
kinase in the cytoplasm regulates autophagy through activation of
AMPK [4,5].
AMPKa, a highly conserved and widely expressed protein
kinase, acts as an intracellular energy sensor [6,7]. Reduced levels
of glucose in normal eukaryotic cells, which increase the AMP
levels (increases the AMP/ATP ratio), activate the AMPKa
through phosphorylation of Thr-172 and also increase its levels
[7]. Several protein kinases can phosphorylate the AMPKa
including the LKB1 [8], ATM [3], and calmodulin-dependent
protein kinase kinase-b [9]. However, in response to energetic
stress, AMPKa is phosphorylated in an ATM-dependent and
LKB1-independent manner [3]. Studies have suggested that the
activation of AMPKa inhibits cell proliferation in both tumor and
nonmalignant cells [10]. Furthermore, a persistent activation of
AMPKa potentiates the p53-dependent cellular senescence in
mouse embryonic fibroblasts (MEFs) [11].
p53 tumor suppressor is activated in cells in response to a
variety of stimuli, including DNA damage, hypoxia, oxidative
stress, and the energetic stress [12,13]. The activation of AMPK in
response to energetic stress induces phosphorylation of p53 at Ser-
15 residue [11,14], resulting in its activation and stabilization,
which increases the p53 protein levels [12]. The activated p53
binds to its DNA-binding consensus sequence that is present in its
target genes [15]. The binding of p53 to its target genes activates
the transcription of genes, such as p21 [16] and IFI16 [17], and
repress the transcription of certain anti-apoptotic genes [15]. The
p53 regulate glucose cellular metabolism [18] and autophagy [19].
It has been shown that MEFs treated with low glucose
concentrations arrest in the G1 phase of the cell cycle [11]. The
arrest depends on the activation of AMPK and phosphorylation of
p53 at Ser-15 [11]. Accordingly, the p53-deficient cells fail to
arrest under low glucose conditions [11]. A study has noted that
glucose deprivation of mouse thymocytes and human osteosarco-
ma cell line U2OS induces phosphorylation of AMPKa and
promotes a p53-dependent decrease in cell survival [14]. Notably,
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protein levels, and the phosphorylation at Ser-46 [14].
Autophagy involves the degradation of cellular components
[20]. The autophagy is regulated by proteins (encoded by
autophagy-related genes or the ATG genes), which participate in
the formation of autophagosomes. Under glucose restriction,
induction of autophagy is thought to provide a nutrient source and
promote cell survival [20,21]. However, under severe glucose
restriction, which results in higher energetic stress, autophagy may
lead to cell death [22]. Consistent with this idea studies indicate
that autophagy may operate upstream of apoptosis [21,22].
Importantly, autophagy regulates infection [23]. Additionally,
autophagy modulates inflammation by activating an inflamma-
some activity and by targeting the pro-IL-1b for degradation
[24,25].
The interferons (IFN) and p53 activate the transcription of the
IFI16 gene (encoding for the IFI16 protein), a member of the
IFI200-genes family [26,27]. The gene encodes for three isoforms
(A, B, and C) of the IFI16 protein through an alternative splicing
of mRNA and the B isoform of the protein is predominant in
HDFs [27]. Upon sensing cytosolic double-stranded DNA
(dsDNA), the IFI16 protein induces the expression of the IFN-b
[28]. The extent of the cytoplasmic and nuclear localization of the
IFI16 protein depends on the cell type [27]. Increased levels of the
IFI16 protein in human primary cells, including the human
diploid fibroblasts (HDFs), are associated with the onset of cellular
senescence [29,30]. Furthermore, the knockdown of IFI16
expression in HDFs results in down-regulation of p21
CIP1 protein
levels and delays the onset of cellular senescence [30]. Consistent
with a role for the IFI16 protein in cellular senescence-associated
cell growth arrest, increased levels of IFI16 protein up-regulate the
expression of p21
CIP1 and inhibit the E2F-mediated transcription
[30]. Notably, ectopic co-expression of the IFI16 protein with p53
in MCF-7 cells enhances the transcription of the known p53 target
genes, such as p21, Hdm2, and Bax [31]. Moreover, the knockdown
of IFI16 expression in MCF-7 cells decreases the phosphorylation
of p53 at Ser-15, following ionizing radiation treatment, and
decreases the p53-mediated apoptosis [31]. IFI16 protein binds to
p53 and increased expression of the IFI16 protein in cells
potentiates the p53-mediated transcriptional activation of the
target genes [32,33].
Given that expression of the IFI16 gene is transcriptionally
activated by p53 [17], increased levels of the IFI16 protein in
HDFs are associated with the onset of cellular senescence [30],
and the energetic stress-induced activation of the AMPK/p53
pathway induces cellular senescence in MEFs [11], we investigated
the potential role of the IFI16 protein in glucose restriction-
induced activation of energetic stress. Here we report that the
IFI16 protein is required for the activation of the ATM/AMPK/
p53 pathway and autophagy upon glucose restriction.
Materials and Methods
Cell Lines, Culture Conditions, and Treatments
Normal human fetal lung fibroblasts WI-38 (AG06814N) at
population doubling (PD) 15 (passage 12) and AT skin fibroblasts
(AG03057) at PD 6 (passage 4) were obtained from the National
Institute of Aging Cell Culture Repository (Coriell Medical for
Medical Research, Camden, NJ). Both WI-38 and AT cell cultures
were maintained (5.5% CO2 and ,21% O2) in DMEM culture
medium with high glucose (4.5 g/L; glucose concentration
equivalent to ,25 mM), which was supplemented with 10% fetal
bovine serum and antibiotics (Invitrogen, Carlsbad, CA). Cell
cultures were regularly split 1: 4 on approaching confluence. Thus,
each cell passage was equivalent to ,2 cell PDs. Sub-confluent
cultures of HDFs, when indicated, were treated with the indicated
reduced concentrations (from 1 mM to 0.25 mM; normal average
glucose concentration in the human serum is ,5 mM) of glucose
by incubating in glucose and pyruvate-free DMEM medium (cat
# 11966-025; Invitrogen) supplemented with 10% fetal bovine
serum. When indicated, cells were treated with either dimethyl
sulphoxide (DMSO; vehicle) alone or 3-methyladenine (from
Sigma; 5 mM concentration) dissolved in DMSO for the indicated
time.
HDFs were collected by trypsinization from cell culture plates
and the number of viable cells in the cultures were counted (in
triplicates) after Trypan Blue staining using Countess Automated
Cell Counter (Invitrogen) and cell counting kit as suggested by the
supplier.
Plasmids and Expression Vectors
The wild-type IFI16-luc-reporter plasmid, which contains the
promoter region (1.677 kb; 1,467 bp upstream of the transcrip-
tional start site) of the IFI16-gene, linked a reporter gene, whose
transcription can be activated by the p53, has been described [17].
Knockdown of the Expression
Young WI-38 HDFs were either infected with control shRNA
particles (sc-108080; from Santa Cruz Biotech, Santa Cruz, CA) or
IFI16 shRNA Lentiviral particles (sc-35633-V, Santa Cruz) in a six
well plate as suggested by the supplier. A day after infections, cells
were selected with puromycin (1 mg/ml) for three days. The
selected cells were pooled and maintained in puromycin (0.5 mg/
ml) for another week. For experiments, cells were cultured without
puromycin for at least three days. The selected cells were analyzed
for the knockdown of IFI16 expression by quantitative PCR as
well as immunoblotting. We were able to reproducibly achieve
,70–90% knockdown of the IFI16 expression.
Immunoblotting and Antibodies
To prepare cell lysates, cells were collected from plates in PBS
and lysed using RIPA buffer supplemented with protease
inhibitors and phosphatase inhibitors as described previously
[17]. The cell lysates were sonicated briefly before centrifugation
at 10,000 rpm in a microfuge for 10 min. The supernatants were
collected and equal amounts of proteins were processed for
immunoblotting. Antibodies specific for IFI16 (sc-8023) and p53
(sc-126) were purchased from Santa Cruz Biotech (Santa Cruz,
CA). Antibodies specific for b-actin (cat # 4967), p-ATM
(ser1981) (cat # 2873), ATM, (cat # 4526), p-AMPK (Thr172)
(cat #2531), AMPK (cat # 2532), p-p53 (ser15) (cat # 9284), p-
p53 (ser46) (cat # 2521) and p-p53 (ser392) (cat # 9281) were
purchased from Cell Signaling Technology (Danvers, MA).
Horseradish peroxidase (HRP) conjugated secondary anti-mouse
(NXA-931) and anti-rabbit (NA-934) antibodies were from
Amersham Biosciences.
HDFs were fractionated into the nuclear and cytoplasmic
fractions as described previously [34]. The detection of the histone
H3 in the nuclear fraction and the IkBa protein in the cytoplasmic
fractions served as the quality control for the cell fractionations.
Reverse Transcriptase Reaction, Real-Time PCR, and qPCR
Array
Total RNA was isolated from WI-38 or AT fibroblasts with
Trizol reagent (Invitrogen, Carlsbad, CA, USA). cDNA synthesis
was done using primers with SuperScript First-strand Synthesis
System for RT-PCR (Invitrogen, Carlsbad, CA, USA). Quantita-
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Foster City, CA, USA) was used. The PCR cycling program
consisted of denaturing at 95uC for 10 min and 40 cycles at 95uC
for 15 seconds, and annealing and elongation at 60uC for 1 min.
The TaqMan assays for IFI16 (assay Id #Hs00194216_m1), p53
(assay Id #Hs00153349 _m1), p21 (assay Id #Hs00355782_
m1), and for the endogenous control b-actin (assay Id#
Hs99999903_ml) were purchased from Applied Biosystems (Foster
City, CA) and used as suggested by the supplier.
To compare expression of pro- and anti-apoptotic genes
between control HDFs and HDFs after the IFI16 expression
knockdown under reduced glucose levels (0.25 mM), we isolated
total RNA from HDFs incubated at either 25 mM or 0.25 mM
glucose for 24 h. cDNA was synthesized as described above and
equal amounts of cDNA was used to performed RT
2 Profiler PCR
Array using human apoptosis PCR array (PAHS-012A-2; from SA
Bioscience, Fredrick, MD) as suggested by the supplier.
ApoTox-Glo Triplex Assay
The assays were performed using a kit from Promega (Madison,
WI). In brief, HDFs were seeded in 96-well plates. After an
overnight incubation of cells, the medium was changed to the
indicated glucose concentration. After 24 h of incubation, the
viability/cytotoxicity reagent containing both GF-AFC substrate
and bis-AAF-R110 substrate were added to the cells as suggested
by the supplier. After about 1 hour incubation at 37 C,
fluorescence was recorded at 400 nm excitation/505 nm emission
for viability and 485 nm excitation/520 nm emission for cytotox-
icity using a microplate reader for fluorescence (SPECTRA max
340PC, Molecular Devices, Sunnyvale, CA). Caspase-Glo 3/7
Reagent was further added to the cells and after ,30 min of
incubation at room temperature, luminescence was recorded using
SpectraMax M2e (Molecular Devices). Numbers of viable,
cytotoxic, and apoptotic cells were measured in triplicates.
Transient Transfection and Dual-Luciferase Assays
All transient transfection assays were performed using FuGene6
transfection reagent (Roche, Indianapolis, IN) according to the
manufacturer’s instructions. In brief, sub-confluent cells were co-
transfected with desired reporter plasmid (IFI16-luc; 1.8 mg DNA)
along with pRL-TK plasmid (0.2 mg) as an internal control. 40–
44 h after transfections of cells, firefly luciferase and Renilla
luciferase activities were assayed using dual-luciferase reporter
assay kit (Promega, Madison, WI). Relative luciferase activity was
expressed as the ratio of the firefly luciferase and Renilla luciferase
activities. Results are mean values of triplicate experiments and
error bars represent standard deviation. The experiments were
repeated at least two times.
Results
Glucose Restriction Activates the ATM/AMPK/p53
Pathway and Induces the Expression of IFI16 Protein
The ratio between AMP/ATP increases in HDFs that
approach cellular senescence [35]. Moreover, treatment of
mouse embryonic fibroblasts with low glucose increases the
AMP/ATP ratio, activates AMPK, and results in phosphoryla-
tion of p53 at Ser-15 residue [11]. The phosphorylation activates
and stabilizes p53 protein, thus, resulting in increases in the p53
protein levels [11]. Given that the expression of IFI16 protein is
induced in old HDFs approaching cellular senescence [30] and
the transcription of the IFI16 gene is activated by wild type p53
[17], we incubated young HDFs with reduced glucose concen-
trations (1.0, 0.5, or 0.25 mM; the normal average glucose
concentration in the human serum is ,5 mM) to increase the
AMP/ATP ratio to explore whether the expression of IFI16 is
up-regulated by p53 that is activated by glucose restriction. As
shown in Fig. 1A, the incubation of HDFs with 1.0 mM
concentration of glucose resulted in the activating phosphoryla-
tion of ATM (Ser-1981), AMPK (Thr-172), and p53 (Ser-15) and
increases in their protein levels. Furthermore, levels of the p53
target proteins, such as p21 and IFI16 (all three isoforms), also
increased (,2–3-fold) under glucose restriction conditions.
Notably, the incubation of HDFs with glucose concentrations
lower than 1.0 mM did not result in further appreciable increases
in the levels of IFI16 protein, indicating that 1.0 mM concen-
tration of glucose was sufficient to induce the expression of the
IFI16 protein. Given that energetic stress that is induced by
glucose restriction is known to induce autophagy and/or cell
death [20–22], we also analyzed extracts for the expression levels
of autophagy proteins. As shown in Fig. 1A, levels of the LC3-II
and ATG7 proteins, markers of autophagy [36], increased with
glucose restriction. Moreover, consistent with reduced cell
viability under reduced glucose conditions, we also noted
increases in levels of cleaved caspase-3 and caspase-1 (Fig. 1A),
markers of cell death by apoptosis [37].
Our observations that WI-38 HDFs can initiate autophagy
activity under glucose restriction prompted us to test whether
treatment of cells with 3-methyladenine (3-MA), an inhibitor of
autophagy [38], could inhibit the activation of the AMPK/p53
pathway and the induction of IFI16 expression under glucose
restriction. As shown in Fig. 1B, the treatment of WI-38 HDFs
with 3-MA reduced steady-state levels of the ATM kinase and the
activating phosphorylation of both AMPK and p53 proteins
(compare lane 4 with 2) under glucose restriction. Importantly,
levels of the IFI16 protein did not increase appreciably after the 3-
MA treatment under glucose restriction (compare lane 4 with 2).
Notably, the difference in the IFI16 protein levels between the
control (lane 2) and 3-MA-treated cells (lane 4) was relatively less
because the treatment of cells with DMSO (the vehicle) alone
increased the levels of IFI16 protein (data not shown). These
observations revealed that treatment of HDFs with 3-MA inhibits
glucose restriction-induced activation of the AMPK/p53 pathway
and the induction of the IFI16 protein.
Treatment of cells with AICAR, an activator of AMPK,
activates the AMPK/p53 pathway [11]. Therefore, we tested
whether treatment of young WI-38 with AICAR could induce the
expression of IFI16 protein. As shown in Fig. 1C, treatment of WI-
38 HDFs with AICAR (0.25 or 0.5 mM), which increased the
activating phosphorylation of AMPKa (at Thr-172) and p53 (at
Ser-15), also increased the steady-state levels of IFI16 protein.
Treatment of cells with metformin, a drug used to treat patients
with type 2 diabetes, also increases the AMP/ATP ratio [37].
Therefore, our above observations that glucose restriction of cells
(or treatment with AICAR) induces the expression of IFI16 protein
prompted us to investigate whether metformin could regulate the
IFI16 expression in HDFs. As shown in Fig. 1D, treatment of
HDFs with the indicated concentrations of metformin for 24 h
increased levels of the IFI16 protein. Interestingly, the increase
was associated with increases in the ATM protein levels and
activation of AMPK and p53. These observations revealed that
metformin-induced activation of the AMPK/p53 pathway can
also induce the expression of the IFI16 protein. Together, these
observations indicated that the energetic stress that is induced in
WI-38 HDFs by glucose restriction, treatment of cells with AICAR
or metformin can activate the ATM/AMPKa/p53 pathway and
the activation is associated with increases in the steady-state levels
of IFI16 protein and the induction of autophagy.
IFI16 in the Regulation of Autophagy
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The IFI16 gene is a transcriptional target of p53 [17].
Therefore, activation of p53 and increases in the IFI16 protein
levels in the above experiments prompted us to test whether the
levels of the IFI16 mRNA also increase in HDFs in response to
energetic stress. As shown in Fig. 2A, steady-state levels of IFI16
mRNA increased ,10-fold in response to reduced glucose
(0.5 mM) in the medium. Consistent with a previous report [14],
levels of p53 and p21 mRNA also increased moderately.
Glucose Restriction-induced IFI16 Protein is detected in
the Cytoplasm and Nucleus
Given that sub-cellular localization of IFI16 protein depends on
the cell type [27], we also assessed the sub-cellular localization of
IFI16 protein in response to the energetic stress that is induced by
glucose restriction. As shown in Fig. 2B, IFI16 protein was
detectable in the cytoplasmic and nuclear fraction in control cells.
Moreover, under glucose restriction, the IFI16 protein accumu-
lated in the nucleus. Consistent with the previous reports [4,5], we
also detected the ATM protein in the cytoplasm and nucleus.
Similarly, both AMPK and p53 were detected both in the
cytoplasm and nucleus. However, glucose restriction resulted in
the accumulation of AMPK primarily in the cytoplasm whereas
the p53 protein in the nucleus. Given that the IFI16 and p53
proteins bind to each other [32,33], the nuclear colocalization of
the IFI16 and p53 proteins under glucose restriction conditions is
consistent with their physical interactions.
Glucose Restriction Decreases Cell Survival
Glucose restriction in cells is known to induce autophagy
[20,21,39] and cell death by apoptosis [20–22]. Therefore, increased
levels of the LC3-II and ATG7 proteins, biomarker for autophagy
[36], and increased cleavage of caspase-3 and caspase-1, markers for
cell death by apoptosis (Fig. 1A), prompted us to investigate whether
theenergeticstressinHDFsreducescellviability.AsshowninFig.3A,
incubation of cells with reduced glucose concentrations resulted in
morphological changes consistent with reduced cell viability (Fig. 3B
and C). Furthermore, we noted that the incubation also increased cell
death by apoptosis (Fig. 3D). Together, these observations revealed
that glucose restriction in WI-38 HDFs under our experimental
conditions induced autophagy and cell death.
Figure 1. Incubation of HDFs under glucose restriction activates the ATM/AMPK/p53 pathway and induces the IFI16 expression. (A)
Sub-confluent cultures of young WI-38 HDFs were incubated with the indicated concentrations (mM) of glucose in the medium supplemented with
10% fetal bovine serum for 18 h. At the end of the incubations, cells were lysed and equal amounts of proteins were analyzed by immunoblotting
using antibodies specific to the indicated proteins. (B) Sub-confluent cultures of young WI-38 HDFs were incubated with the indicated concentrations
(mM) of glucose in the medium without any treatment (lanes 1 and 2), with DMSO (lane 3) or with 3-methyladenine (5 mM; lane 4) for 18 h. At the
end of the incubations, cells were lysed and equal amounts of proteins were analyzed by immunoblotting using antibodies specific to the indicated
proteins. (C) Sub-confluent cultures of young WI-38 HDFs were incubated with the indicated concentrations (mM) of AICAR in the medium
supplemented with 10% fetal bovine serum for 18 h. At the end of the incubations, cells were lysed and equal amounts of proteins were analyzed by
immunoblotting using antibodies specific to the indicated proteins. (D) Sub-confluent cultures of young WI-38 HDFs were incubated with the
indicated concentrations (mM) of metformin in the medium for 24 h. At the end of the incubations, cells were lysed and equal amounts of proteins
were analyzed by immunoblotting using antibodies specific to the indicated proteins.
doi:10.1371/journal.pone.0019532.g001
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Levels is ATM-Dependent
Activation of ATM protein kinase by glucose restriction in
HDFs has not been reported previously. Therefore, our observa-
tions that glucose restriction (Fig. 1A) increases the activating
phosphorylation of ATM protein kinase prompted us to test
whether the activation of energetic stress in HDFs is the ATM-
dependent. As shown in Fig. 4A, incubation of young (passage 6)
AT HDFs under reduced glucose concentrations (1.0 or 0.5 mM)
for 24 h did not result in any appreciable morphological changes.
Moreover, we noted accumulation of cells primarily in the G1
phase of the cell cycle at the expense of the S-phase (data not
Figure 2. Glucose restriction increases steady-state levels of IFI16, p53, and p21 mRNA and increased levels of IFI16 protein are
detected in the cytoplasmic and nuclear fractions. (A) Total RNA isolated from WI-38 cells incubated with the indicated concentration of
glucose for 18 h was subjected cDNA synthesis, followed by quantitative real-time PCR using the TaqMan assay for the IFI16, p53, and p21 genes. (B)
Sub-confluent cultures of HDFs were incubated with the indicated concentrations of glucose in the medium for 18 h. At the end of the incubation,
cells were fractionated into the cytoplasmic and nuclear fractions as described in methods. The fractions containing equal amounts of the protein
were analyzed by immunoblotting using antibodies to the indicated proteins.
doi:10.1371/journal.pone.0019532.g002
Figure 3. Glucose restriction decrease cell survival. (A) Sub-confluent cultures of young WI-38 HDFs were incubated with the indicated
concentrations (mM) of glucose in the medium supplemented with 10% fetal bovine serum for 24 h. At the end of the incubations, cells were
photographed using a phase contrast microscope. (B) At the end of the incubation of HDFs shown in the panel (A), the number of viable cells were
counted (in triplicates) by Trypan Blue exclusion method using the Countess Automated Cell Counter (Invitrogen). (C and D) HDFs (in triplicates)
were grown in 96-well plates and cells were incubated at the indicated concentrations of glucose for either 24 h (white bars) or 48 h (black bars). At
the end of the incubations, cell viability and the extent of apoptosis were determined using ApoTox-Glo Triplex Assay (Promega) as described in the
method. Experiments were repeated three times, which gave similar results.
doi:10.1371/journal.pone.0019532.g003
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in the activating phosphorylation of AMPK or p53 under reduced
glucose concentrations (1.0 mM; Fig. 4B). Notably, the levels of
IFI16 protein did not increase appreciably and levels of IFI16
mRNA decreased .70% under reduced glucose conditions
(Fig. 4C). Accordingly, no measurable changes in the mRNA
levels of p53 and p21 were evident. Moreover, the activity of the
IFI16-luc reporter, the transcription of which is driven by the 59-
regulatory region of the IFI16 gene [17], was not stimulated by the
reduced glucose concentration (0.25 mM) in the medium (Fig. 4D).
Together, these observations suggested that AT HDFs are
defective in glucose restriction-induced activation of the AMPK/
p53 pathway and the induction of the IFI16 expression.
Glucose Restriction-induced Expression of IFI16 Protein
Contributes to Activation of the ATM/AMPK/p53-
pathway
To examine the potential role of the IFI16 protein in the glucose
restriction-induced activation of the ATM/AMPK/p53 pathway,
we knockdown the expression of IFI16 protein in the young WI-38
HDFs (Fig. 5A and B) and compared the activation of the pathway
by glucose restriction between the control cells and after the
knockdown of IFI16 expression. As shown in Fig. 5B, the
knockdown (,70% reduction) of IFI16 expression in WI-38
HDFs, under reduced glucose conditions, decreased the activating
phosphorylation of ATM, AMPK, and p53 (Fig. 5B). Notably, the
basal levels of caspase-3 also decreased in HDFs with reduced
levels of the IFI16 protein and the energetic stress resulted in only
moderate increases in the levels. In addition, basal levels of pro-
apoptotic protein Bad, a transcriptional target of p53, decreased
whereas basal levels of anti-apoptotic protein BCL-xL increased in
cells with the reduced IFI16 protein levels. Furthermore, no
increase in levels of Caspase-7 was evident under energetic stress
in cells with reduced IFI16 protein levels. Consistent with these
observations, the knockdown of IFI16 expression in HDFs also
decreased the morphological changes (Fig. 5C) that were
associated with reduced cell survival under reduced glucose
concentrations (Fig. 3). Together, these observations revealed that
the IFI16 protein contributes to the activation of the ATM/
AMPK/p53 pathway during the glucose restriction and the
reduced levels of the IFI16 protein in cells increase cell survival by
modulating the expression of the p53-regulated apoptosis-
regulatory proteins.
IFI16 Protein Potentiates the p53-mediated
Transcriptional Activation
Phosphorylation of p53 at Ser-15 or Ser-46 is associated with
energetic stress-induced metabolic checkpoint and induction of
apoptosis [40,41]. Moreover, the IFI16 protein alters the
phosphorylation of p53 in human MCF-7 [31] and endothelial
[42] cells. Therefore, we investigated whether the knockdown of
IFI16 expression in HDFs affects phosphorylation of p53 protein
under glucose restriction. As shown in Fig. 6A, glucose restriction
increased IFI16 protein levels (compare lane 2 with 1). Notably,
the increase in the IFI16 protein levels in lane 2 is moderate due to
reduced protein levels (compare actin protein levels between lane 2
and 1). Importantly, the knockdown of IFI16 expression in young
WI-38 HDFs resulted in increased basal phosphorylation of the
p53 at the Ser-392 and reduced basal phosphorylation of p53 at
Ser-46. Moreover, the energetic stress, which increased p53
Figure 4. Glucose restriction-induced activation of the AMPK/p53 pathway and increase in the IFI16 protein levels are ATM-
dependent. (A) Sub-confluent cultures of young AT HDFs were incubated with the indicated concentrations (mM) of glucose in the medium
supplemented with 10% fetal bovine serum for 18 h. At the end of the incubations, cells were photographed using a phase contrast microscope at a
lower magnification. (B) Sub-confluent cultures of young AT HDFs were incubated with the indicated concentrations (mM) of glucose in the medium
supplemented with 10% fetal bovine serum for 18 h. At the end of the incubations, cells were lysed and equal amounts of proteins were analyzed by
immunoblotting using antibodies specific to the indicated proteins. (C) Total RNA isolated from AT HDFs incubated with the indicated concentration
of glucose for 18 h was subjected cDNA synthesis, followed by quantitative real-time PCR using the TaqMan assay for the IFI16, p53, and p21 genes.
(D) Sub-confluent cultures of young WI-38 or AT HDFs were transfected with the IFI16-luc reporter plasmid (1.8 mg) along with a second reporter pRL-
TK (0.2 mg) plasmid as an internal control. After transfections, cells were incubated with the indicated concentrations of glucose. 40–44 h after
transfections, firefly luciferase and Renilla luciferase activities were assayed using dual-luciferase reporter assay kit. Relative luciferase activity was
expressed as the ratio of the firefly luciferase and Renilla luciferase activity. The numbers indicate fold change in the activity of the firefly luciferase.
The experiments were repeated two times with essentially similar results.
doi:10.1371/journal.pone.0019532.g004
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restriction. (A) Total RNA isolated from WI-38 HDFs either infected with control or IFI16 shRNA lentivirus particles was subjected cDNA synthesis,
followed by quantitative real-time PCR using the TaqMan assay for the IFI16 gene. (B) Sub-confluent cultures of young WI-38 HDFs either infected
with control (Vector) or IFI16 shRNA lentivirus particles (shIFI16) were incubated with the indicated concentrations (mM) of glucose in the medium
supplemented with 10% fetal bovine serum for 18 h. At the end of the incubations, cells were lysed and equal amounts of proteins were analyzed by
immunoblotting using antibodies specific to the indicated proteins. (C) Sub-confluent cultures of young WI-38 HDFs either infected with control (top
panel) or IFI16 shRNA lentivirus particles (lower panel) were incubated with the indicated concentrations (mM) of glucose in the medium
supplemented with 10% fetal bovine serum for 18 h. At the end of the incubations, cells were photographed using a phase contrast microscope.
doi:10.1371/journal.pone.0019532.g005
Figure 6. IFI16 protein potentiates the p53-mediated transcriptional activation through the regulation of phosphorylation. (A) Sub-
confluent cultures of young WI-38 HDFs either infected with control (Vector) or IFI16 shRNA lentivirus particles (shIFI16) were incubated with the
indicated concentrations (mM) of glucose in the medium supplemented with 10% fetal bovine serum for 18 h. At the end of the incubations, cells
were lysed and equal amounts of proteins were analyzed by immunoblotting using antibodies specific to the indicated proteins. (B) Young WI-38
HDFs either infected with control or IFI16 shRNA lentivirus particles were incubated with medium containing reduced glucose concentration
(0.25 mM) for 18 h. At the end of the incubation, total RNA was isolated and subjected cDNA synthesis. The cDNA preparation was used for RT
2
Profiler PCR Array for human apoptosis genes as described in Methods. Genes whose expression was increased or decreased more than 4-fold are
indicated.
doi:10.1371/journal.pone.0019532.g006
IFI16 in the Regulation of Autophagy
PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e19532phosphorylation at Ser-46 in control cells, was inhibited in HDFs
with reduced IFI16 protein levels. Interestingly, phosphorylation
of p53 at Ser-15 did not increase under reduced glucose conditions
in HDFs with reduced IFI16 protein levels. Notably, the p53
protein levels did not increase in HDFs with reduced IFI16 protein
levels under glucose restriction. Accordingly, we noted changes in
the steady-state levels of mRNAs encoded by the p53 target genes
between control HDFs and HDFs with the reduced IFI16 protein
levels under the energetic stress (Fig. 6B). We found that the
steady-state levels of mRNAs corresponding to the TP73 and
BCL2L1 genes were reduced .10-fold. In contrast, the steady-
state levels of CIDEA, BNIP2, CASP7, and BAD mRNAs were
increased 4–27-fold. These observations suggested that the
increased levels of the IFI16 protein under glucose restriction
modulate the p53-mediated cell survival by modulating the
phosphorylation of p53 and the expression of its target genes.
Discussion
In the current study, we investigated the regulation and role of
the IFI16 protein, a transcriptional target of the p53 and a growth
suppressor [17,27], in energetic stress-induced signaling in HDFs.
We found that the energetic stress due to glucose restriction,
treatment of HDFs with AICAR or metformin activated the
ATM/AMPK/p53 pathway. Interestingly, the activation of the
pathway was associated with increases in steady-state levels of
IFI16 protein (Fig. 1) and mRNA (Fig. 2A). The increased levels of
IFI16 protein were detected in the cytoplasmic as well as in the
nuclear fraction (Fig. 2B). Moreover, the increased levels of the
IFI16 protein were associated with autophagy (Fig. 1A) and
decreased cell viability (Figs. 1 and 3). In contrast, the knockdown
of IFI16 expression in HDFs under glucose restriction inhibited
the activation of the pathway and also increased cell survival
(Fig. 5). These observations are novel and are consistent with the
idea that the disruption of energetic stress-induced checkpoint
through the loss of the ATM function, as is the case in AT cells, or
the loss of p53 or IFI16 function, as is the case in certain human
cancers, may provide a growth advantage to cells under energetic
stress. Moreover, these observations also support the idea that the
energetic stress-induced increased levels of the IFI16 protein in
cells contribute to autophagy (Fig. 7).
Depending upon glucose restriction-induced energetic stress
levels, autophagy in cells is thought to promote either cell survival
or induce cell death [20–23]. Interestingly, we noted that glucose
restriction consistently reduced survival of WI-38 HDFs in several
independent experiments. We also noted cleavage of both caspase-
3 and caspase-1 (Fig. 1A) with reduced cell survival (Fig. 3),
suggesting some cell death by apoptosis in glucose restricted WI-38
HDFs. Given that studies indicate p53-dependent apoptosis [19]
as well as atypical form of apoptosis [22] in glucose restricted cells,
it is likely that reduced cell survival under our experimental
conditions is due to both apoptosis (in an early stage when energy
is still available to cells) and necrosis. Further work is in progress to
understand the molecular mechanisms by which glucose restric-
tion induces autophagy and cell death in HDFs.
The onset of cellular senescence is thought to protect against the
initiation of tumor formation in response to certain cellular
stresses, including the genotoxic and energetic stress [43]. It is
known that environmental factors that place oxidative stress on
cells promote the early onset of cellular senescence and increase
the AMP: ATP ratio significantly (,30-fold) [35], which results in
energetic stress and activation of a stress pathway involving the
AMPK and p53 [11]. Our observations that energetic stress that is
induced by glucose restriction (or treatment of cells with AICAR
or metformin) can activate the ATM/AMPK/p53 pathway in
HDFs and the activation is associated with increases in the IFI16
protein levels make it likely that the increased levels of IFI16
protein in cells contribute to cellular senescence associated cell
growth arrest.
Others have reported that AMPK activate a nutrient-sensitive
signaling pathway that initiates p53-dependent cell-cycle arrest
during times of energy deficiency [11]. Thus, p53 serves as a
metabolite sensor and, depending upon cell type and the strength
of the stress, coordinates cell survival, resulting in reversible cell-
cycle arrest, cellular senescence, or reduced cell viability [11,14].
In response to certain cellular stresses, p53 is phosphorylated on
several amino acid residues [40,41]. These residues include Ser-
15, Ser-20, and Ser-46. Phosphorylation of p53 protein at Ser-46
after severe DNA damage results in apoptotic cell death.
Therefore, it has been proposed that the stress-induced phosphor-
ylation of p53 at Ser-46 is one of the critical events for
commitment of cell fate into apoptotic cell death [40,41]. Given
that IFI16 protein binds to p53 and potentiates the p53-mediated
transcription [32,33], our observations that the knockdown of
IFI16 expression in HDFs reduced phosphorylation of p53 at Ser-
46 in response to the energetic stress (Fig. 6) make it likely that the
IFI16 protein regulates cell survival of HDFs under glucose
restriction by regulating the phosphorylation of p53 and, thus,
altering the expression of its target genes that encode for apoptosis
regulating proteins (Fig. 6).
Activation of the ARK5, a relatively new member of the human
AMP-activated protein kinase (AMPK) family, during nutrient
starvation is shown to support cell survival [44]. In addition, the
activated ARK5 protein kinase can phosphorylate the ATM and
p53 proteins [44]. Therefore, our observations that under glucose
restriction the ATM is phosphorylated at Ser-1981 in HDFs are
consistent with the possibility that energetic-stress induced kinases,
such as ARK5, may activate both ATM and p53. Further work
will be needed to test this possibility.
Figure 7. Proposed model for the regulation and role of the
IFI16 protein in glucose restriction-induced activation of the
ATM/AMPK/p53 pathway and autophagy.
doi:10.1371/journal.pone.0019532.g007
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oxidative damage, which is considered as one of the key factor in
cellular aging [45]. Cellular DNA damage (particularly the
induction of DSBs) results in activating phosphorylation of ATM
at Ser-1981 and histone H2AX at Ser-139 [46]. The phosphor-
ylation of these two proteins serves as marker for oxidative DNA
damage. Cells under normal culture conditions (20% O2) exhibit
basal oxidative damage as indicated by the constitutive phosphor-
ylation of both ATM and H2AX [46]. Moreover, the extent of
phosphorylation of these proteins reflects the extent of oxidative
DNA damage. Therefore, our observations that the knockdown of
IFI16 expression in young HDFs reduced the constitutive
phosphorylation of both H2AX and ATM (Fig. 5B) are consistent
with our previous observations that the increased levels of IFI16
protein in old HDFs are associated with the activation of p53,
increased expression of p21, and the onset of cellular senescence
[30]. Furthermore, we noted that incubation of young WI-38
HDFs at lower (1%) O2 levels reduced steady-sate levels of the
IFI16 mRNA and protein by 50–70% within 24 h of incubation
(data not shown). Therefore, it is likely that incubation of WI-38
HDFs under our culture conditions (20% O2) and glucose
restriction-induced stress both contribute to the increased levels
of the IFI16 protein.
Cells respond to oxidative stress and energy depletion with the
induction of autophagy [19,39]. Therefore, our observation that
increases in the IFI16 protein levels in HDFs in response to
glucose restriction are associated with increases in levels of the
LC3-II and ATG7 proteins, markers of the induction of
autophagy [36], raise the possibility that the increased levels of
IFI16 protein in HDFs contribute to glucose deprivation-induced
increases in reactive oxygen species (ROS) and, thereby, depletion
of ATP and cell death. Accordingly, we noted that the knockdown
of IFI16 levels in HDFs reduced glucose deprivation-induced
increase in the phosphorylation of H2AX and ATM, and cell
death (Fig. 5). Moreover, these results are also consistent with the
idea that the loss of IFI16 expression, as found in human cancers
[27], could provide a survival advantage to tumor cells in
microenvironments with glucose restriction.
In summary, our observations demonstrate a role for the IFI16
protein in the energetic stress-induced activation of the ATM/
AMPK/p53 pathway (Fig. 7) and autophagy. At present, it is not
clear how ATM protein kinase is phosphorylated in response to
the energetic stress. Given that reduced levels of glucose are known
to generate reactive oxygen species (ROS) [47], it is likely that the
oxidative stress activates the ATM kinase. Notably, glucose
deprivation of cells and their ability to survive under low glucose
conditions can drive the acquisition of KRAS pathway mutations in
human tumors [48]. In this context, it is interesting to note that the
loss of IFI16 expression in human colon cancer cell lines is
associated with KRAS mutations [21]. Therefore, further studies
will be needed to examine the role of IFI16 protein in the
energetic-stress-induced metabolic pathways, autophagy, cell
survival, and the development of cancers.
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